Clik here to view.
Inventia Life Science Accelerates Growth with $25M Series B and Launches 3D...
SYDNEY Inventia Life Science, a world leader in advanced 3D cell cultures for research and clinical purposes, has today announced the close of a US $25M Series B funding round, led by Blackbird...
View ArticleClik here to view.
enlightenVue™ Receives Chinese Patent Covering Core Technology for its...
DENVER enlightenVue™, Inc. announced today that China has granted the company a patent covering the core technology underlying its surgiVue™ single-use micro-endoscope platform. The patented...
View ArticleClik here to view.
MDoloris Medical Systems ＆ Mindray Announce the CE Mark and Launch of Their...
PARIS & SHENZHEN, China MDoloris Medical Systems, leader in the field of objective analgesia/nociception monitoring during anesthesia and in intensive care, and Mindray, a global leader in...
View ArticleClik here to view.
Dr. Reddy’s and Prestige BioPharma announce partnership to commercialize...
HYDERABAD, India Prestige BioPharma and Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, hereafter referred to as “Dr. Reddy’s”) today announced that the two...
View ArticleClik here to view.
マシモ製のSedLine®脳機能モニタリングが術後せん妄発現のリスクを持つ患者の早期発見に役立つ可能性を示す新研究
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、Anesthesia & Analgesia誌に掲載された前向き研究の知見を発表しました。本研究では、Claudia Spies医師と同僚らが、待機的手術を受ける高齢患者を対象に、Masimo...
View ArticleClik here to view.
Sosei Heptares Enters Antibody Discovery Agreement with Twist Bioscience to...
SOUTH SAN FRANCISCO, Calif. Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and...
View ArticleClik here to view.
Navient 神外手术导航系统获得中国监管部门许可
多伦多 ClaroNav Inc的子公司ClaroNav Kolahi Inc欣然宣布，公司已获得中国国家药品监督管理局（NMPA）的监管许可，可在中国市场销售其Navient神外手术导航 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20211216005916/zh-CN/ Navient...
View ArticleClik here to view.
Navient Neuro-navigation System Receives Chinese Regulatory Clearance
TORONTO ClaroNav Kolahi Inc, a subsidiary of ClaroNav Inc, is pleased to announce that it has received Chinese regulatory clearance from the National Medical Products Administration (NMPA) to market...
View ArticleClik here to view.
Takeda Receives Positive CHMP Opinion for Vedolizumab IV for the Treatment of...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...
View ArticleClik here to view.
Personalis推出基于肿瘤信息的液相活检分析法NeXT Personal™，检测MRD和复发的灵敏度可达百万分之一
加州门洛帕克 (美国商业资讯)–先进癌症基因组学的领导者Personalis, Inc. (Nasdaq: PSNL)今天宣布推出NeXT Personal，这是一种新一代基于肿瘤信息的液相活检分析方法，旨在检测和量化有既往癌症诊断史患者的分子残留疾病(MRD)和复发。NeXT...
View ArticleClik here to view.
BeiGene Announces Launch of Bioisland Innovation Center
CAMBRIDGE, Mass. & BEIJING BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global, science-driven biotechnology company focused on developing innovative and affordable medicines, today...
View ArticleClik here to view.
BeiGene Expands Collaboration with Novartis to Develop and Commercialize...
BASEL, Switzerland & CAMBRIDGE, Mass. & BEIJING BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global science-driven biotechnology company, today announced an option,...
View ArticleClik here to view.
CG Oncology Announces First Patient Dosed in Japan in Phase 3 Monotherapy...
IRVINE, Calif. CG Oncology, Inc., a clinical-stage biotechnology company focused on developing oncolytic immunotherapies for patients with advanced cancer, announced today it has triggered the first...
View ArticleClik here to view.
ITM and ANSTO Announce Extension of Licensing Agreement for the Production...
MUNICH & SYDNEY ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company, and the Australian Nuclear Science and Technology Organisation (ANSTO), a public research...
View ArticleClik here to view.
Ligand’s Partner CStone Pharmaceuticals Receives Approval in China for...
EMERYVILLE, Calif. Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that its partner CStone Pharmaceuticals (HKEX: 2616) has received approval from China’s National Medical...
View ArticleClik here to view.
Curia Unveils Comprehensive mRNA Solution
ALBANY, N.Y. Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today unveiled its messenger RNA (mRNA) solution, which includes discovery, process...
View ArticleClik here to view.
Patritumab Deruxtecan Granted U.S. FDA Breakthrough Therapy Designation in...
TOKYO, MUNICH & BASKING RIDGE, N.J. Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy...
View ArticleClik here to view.
DESTINY-Lung04 Phase 3 Trial of ENHERTU® Initiated in Patients with...
TOKYO & MUNICH & BASKING RIDGE, N.J. Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the first patient was dosed in the global DESTINY-Lung04 phase 3 trial...
View ArticleClik here to view.
Accutar Biotechnology Announces FDA Clearance of IND Application for Phase 1...
BROOKLYN, N.Y. Accutar Biotechnology, Inc., a biotechnology company focusing on artificial intelligence (AI)-empowered drug discovery, today announced that the U.S. Food and Drug Administration...
View ArticleClik here to view.
Accutar Biotechnology、前立腺がんを対象としたAC0176の第1相臨床試験のIND申請をFDAが承認したと発表
米ニューヨーク州ブルックリン （ビジネスワイヤ） — 人工知能（AI）の力を活用した創薬に傾注するバイオテクノロジー企業のAccutar Biotechnology,...
View Article